No Signs of the DOJ Letting Off the Pedal with Medicare Fraud Investigations
However, a new memo instructs federal prosecutors to ‘avoid overreach’ when parties cooperate with authorities
However, a new memo instructs federal prosecutors to ‘avoid overreach’ when parties cooperate with authorities
From - Lab Compliance Advisor
Fraudulent utilization and billing of urine drug screening first became a priority for federal enforcers since the…
From - Lab Compliance Advisor
Question: What happens when multiple whistleblowers bring separate qui tam lawsuits against a lab for the same offense…
From - Lab Compliance Advisor
It's not just new laws, regulations or even court cases. Trends in health care fraud enforcement are sometimes driven by changes in prosecution policies, including…
From - Lab Compliance Advisor
It wasn't the outcome the four hospital employees envisioned when they filed their lawsuit charging the…
From - Lab Compliance Advisor
Recent federal legislation addressing the opioid crisis may have unintended consequences on the lab industry. The idea was to allow the feds to prosecute a certain kind of…
From - G2 Compliance Advisor
Pop Quiz: What's the highest amount a health care entity ever paid to the HHS Office for Civil Rights (OCR) to settle a HIPAA violation…